200 related articles for article (PubMed ID: 14993096)
1. Selectivity of (3)H-MADAM binding to 5-hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioural effects.
Larsen AK; Brennum LT; Egebjerg J; Sánchez C; Halldin C; Andersen PH
Br J Pharmacol; 2004 Mar; 141(6):1015-23. PubMed ID: 14993096
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of N,N-dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity.
Chalon S; Tarkiainen J; Garreau L; Hall H; Emond P; Vercouillie J; Farde L; Dasse P; Varnas K; Besnard JC; Halldin C; Guilloteau D
J Pharmacol Exp Ther; 2003 Jan; 304(1):81-7. PubMed ID: 12490578
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological and genetic characterization of two selective serotonin transporter ligands: 2-[2-(dimethylaminomethylphenylthio)]-5-fluoromethylphenylamine (AFM) and 3-amino-4-[2-(dimethylaminomethyl-phenylthio)]benzonitrile (DASB).
Li Q; Ma L; Innis RB; Seneca N; Ichise M; Huang H; Laruelle M; Murphy DL
J Pharmacol Exp Ther; 2004 Feb; 308(2):481-6. PubMed ID: 14610240
[TBL] [Abstract][Full Text] [Related]
4. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
[TBL] [Abstract][Full Text] [Related]
5. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
Hirano K; Kimura R; Sugimoto Y; Yamada J; Uchida S; Kato Y; Hashimoto H; Yamada S
Br J Pharmacol; 2005 Mar; 144(5):695-702. PubMed ID: 15678084
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties.
Pullar IA; Boot JR; Carney SL; Cohen ML; Colvin EM; Conway RG; Hardy CH; Lucaites VL; Nelson DL; Schenck KW; Tomlinson R; Wedley S
Eur J Pharmacol; 2001 Nov; 432(1):9-17. PubMed ID: 11734182
[TBL] [Abstract][Full Text] [Related]
7. Binding of S-citalopram and paroxetine discriminates between species.
Elfving B; Wiborg O
Synapse; 2005 Mar; 55(4):280-2. PubMed ID: 15668984
[No Abstract] [Full Text] [Related]
8. Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.
Jarkas N; McConathy J; Voll RJ; Goodman MM
J Med Chem; 2005 Jun; 48(13):4254-65. PubMed ID: 15974579
[TBL] [Abstract][Full Text] [Related]
9. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP
J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503
[TBL] [Abstract][Full Text] [Related]
10. Chronoamperometry to determine differential reductions in uptake in brain synaptosomes from serotonin transporter knockout mice.
Perez XA; Andrews AM
Anal Chem; 2005 Feb; 77(3):818-26. PubMed ID: 15679349
[TBL] [Abstract][Full Text] [Related]
11. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors.
Chen F; Larsen MB; Sánchez C; Wiborg O
Eur Neuropsychopharmacol; 2005 Mar; 15(2):193-8. PubMed ID: 15695064
[TBL] [Abstract][Full Text] [Related]
12. Non-amines, drugs without an amine nitrogen, potently block serotonin transport: novel antidepressant candidates?
Goulet M; Miller GM; Bendor J; Liu S; Meltzer PC; Madras BK
Synapse; 2001 Dec; 42(3):129-40. PubMed ID: 11746710
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization and visualization of the glial serotonin transporter.
Inazu M; Takeda H; Ikoshi H; Sugisawa M; Uchida Y; Matsumiya T
Neurochem Int; 2001 Jul; 39(1):39-49. PubMed ID: 11311448
[TBL] [Abstract][Full Text] [Related]
14. Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.
Orjales A; Mosquera R; Toledo A; Pumar MC; García N; Cortizo L; Labeaga L; Innerárity A
J Med Chem; 2003 Dec; 46(25):5512-32. PubMed ID: 14640559
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters.
Ravna AW; Sylte I; Dahl SG
J Pharmacol Exp Ther; 2003 Oct; 307(1):34-41. PubMed ID: 12944499
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of the cloned human 5-hydroxytryptamine transporter.
Agnel M; Esnaud H; Langer SZ; Graham D
Biochem Pharmacol; 1996 May; 51(9):1145-51. PubMed ID: 8645336
[TBL] [Abstract][Full Text] [Related]
17. LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine(2A) receptor antagonist: a comparison with the antidepressant, nefazodone.
Pullar IA; Carney SL; Colvin EM; Lucaites VL; Nelson DL; Wedley S
Eur J Pharmacol; 2000 Oct; 407(1-2):39-46. PubMed ID: 11050288
[TBL] [Abstract][Full Text] [Related]
18. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
Millan MJ; Gobert A; Lejeune F; Newman-Tancredi A; Rivet JM; Auclair A; Peglion JL
J Pharmacol Exp Ther; 2001 Aug; 298(2):565-80. PubMed ID: 11454918
[TBL] [Abstract][Full Text] [Related]
19. [11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats.
Ginovart N; Wilson AA; Meyer JH; Hussey D; Houle S
Synapse; 2003 Feb; 47(2):123-33. PubMed ID: 12454950
[TBL] [Abstract][Full Text] [Related]
20. Studies of the biogenic amine transporters. XI. Identification of a 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) analog that allosterically modulates the serotonin transporter.
Nightingale B; Dersch CM; Boos TL; Greiner E; Calhoun WJ; Jacobson AE; Rice KC; Rothman RB
J Pharmacol Exp Ther; 2005 Aug; 314(2):906-15. PubMed ID: 15860577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
